Search Results
384 items found for "Jillian G Baker"
- Drug Discovery Picks Up the Pace, Stays on Target
high-throughput drug screening, drug efficacy analyses, and toxicity studies; technologies that stabilize G
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR),
- Prostaglandin signaling in ciliogenesis and development
Many G-protein-coupled receptors (GPCRs) including EP4 are localized in cilia for modulating cAMP signaling
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
4,5-bisphosphate (PI(4,5)P2) lipids have been shown to stabilize an active conformation of class A G-protein
- Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
Besides G-proteins and β-arrestins, 14-3-3 proteins participate in GPCR trafficking and signaling, and
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
antagonist and agonist ligands "The CX3C chemokine receptor 1 (CX3CR1), a member of the class A of G
- Functional modulation of PTH1R activation and signaling by RAMP2
Receptor-activity-modifying proteins (RAMPs) are ubiquitously expressed membrane proteins that associate with different G
- 📰 GPCR Weekly News, June 5 to 11, 2023
Hexahydroquinoline Derivatives are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1 The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming
- 📰 GPCR Weekly News, August 14 to 20, 2023
to 20, 2023 Adhesion GPCRs Amelioration of non-alcoholic fatty liver disease by targeting adhesion G that a glucagon-bound extracellular domain of the glucagon receptor is dynamic Ligand recognition and G
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
recruitment, activation, and scaffolding of numerous cytoplasmic signaling complexes and assist in G-protein
- 📰 GPCR Weekly News, February 13 to 19, 2023
Anionic phospholipids control mechanisms of GPCR-G protein recognition. Reviews, GPCRs, and more Single nucleotide variations encoding missense mutations in G protein-coupled
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
the gut-brain axis, have entered a strategic research collaboration to identify and validate novel G
- GPCR kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by...
September 2022 "G protein-coupled receptor (GPCR) kinases (GRKs) and arrestins mediate GPCR desensitization
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
September 2022 "The G-protein-coupled bile acid receptor, Gpbar1 or TGR5, is characterized as a membrane
- Newly launched antibody libraries put hard-to-drug targets within reach
To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better
- GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP
October 2022 "Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor (GPCR) activated by
- Comparative study of neuropeptide signaling systems in Hemiptera
Here, 33 neuropeptide precursors and 48 putative neuropeptide G protein-coupled receptor (GPCR) genes
- ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the...
Single nucleotide polymorphisms (SNPs) in the Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are
- 📰 GPCR Weekly News, September 25 to October 1, 2023
non-nutritive sweetener sucralose increases β-arrestin signaling at the constitutively active orphan G complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency G Receptor Agonist GSBR-1290 and Provides Program Update Septerna sells GPCR program to Vertex for $48 million
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
Ghent, Belgium – March 10, 2022 – Confo Therapeutics , a leader in the discovery of medicines targeting G-protein
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
Pharmacology in Cell Membranes and Living Cells "Conformational biosensors to monitor the activation state of G
- Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells
In this work, we report the subcellular localization of histamine receptor 2 (H2R), a G protein-coupled
- 📰 GPCR Weekly News, March 20 to 26, 2023
Loss of biased signaling at a G protein-coupled receptor in overexpressed systems. Methods & Updates in GPCR Research The application of targeted protein degradation technologies to G
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
inflammasome activation in macrophages "The putative medium-chain free fatty acid receptor GPR84 is a G
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
actin cytoskeleton in regulating the dynamics of the serotonin1A receptor, a crucial neurotransmitter G
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
variety of behavioral processes and physiological functions in invertebrates through the interaction with G-protein-coupled
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal Stability to the Serotonin 1A Receptor "G
- 📰 GPCR Weekly News, July 31 to August 6, 2023
dynamic simulations Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein Oskar Industry News Addex GABAb Positive Allosteric Modulator Program To Receive Additional Chf 2.7 Million Half-Year 2023 Financial Results And Host Conference Call On August 10, 2023 X4 Pharmaceuticals Closes $115 Million Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2023 Septerna: $150 Million Raised To Discover And Advance Novel Oral Small Molecule Medicines Targeting G Protein-Coupled Receptors